A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
Bayer
Cedars-Sinai Medical Center
Prelude Therapeutics
Cedars-Sinai Medical Center
Quadriga Biosciences, Inc.
Celgene
AbbVie
Celgene
Celldex Therapeutics
Stanford University
Icahn School of Medicine at Mount Sinai
Stanford University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Pharmacyclics LLC.
Siemens Molecular Imaging